EBS
Emergent Biosolutions Inc
6.80$
-3.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.8% | 9.1% | 10.9% | 37.1% | 5.3% | 17.0% | 34.0% | 18.1% | -3.1% | -19.7% | 5.6% | 23.0% | |
| 8.0% | 7.2% | 7.8% | 7.6% | 7.9% | 10.0% | 7.3% | 7.0% | 12.8% | 11.9% | 10.4% | 12.9% | |
| 3.2% | 3.2% | 3.8% | 2.7% | 3.0% | 2.4% | 3.3% | 2.4% | 4.0% | 2.2% | 1.7% | 2.2% | |
| 6.9% | 4.7% | 1.8% | 5.2% | 4.6% | 5.6% | 6.6% | 6.7% | 3.7% | – | – | – | |
| 3.3% | -13.5% | -9.3% | 9.6% | -15.2% | -3.8% | 0.6% | -8.8% | -0.2% | -6.7% | 8.5% | -3.0% | |
| 7.6% | 9.2% | 15.6% | 9.8% | 9.2% | 7.9% | 9.0% | 12.7% | 10.4% | 4.9% | 2.2% | 1.9% | |
| -51.9% | -9.3% | -15.6% | -44.6% | -114.7% | -8.8% | -9.6% | -12.7% | -34.1% | 20.2% | 12.0% | 9.3% | |
| 11.1% | 0.0% | 0.0% | 0.0% | – | 0.1% | 1.1% | 0.9% | – | 0.5% | – | – | |
| 0.0% | 0.0% | -0.2% | -5.9% | 0.0% | -0.7% | -0.9% | -6.0% | -7.3% | -7.8% | 2.3% | -3.4% | |
| 44.6% | 0.4% | -4.1% | -4.0% | 100.1% | 1.2% | 3.5% | -2.0% | 50.5% | -51.8% | -19.0% | -14.6% | |
| 49.2% | 6.8% | -3.8% | -9.2% | 100.8% | -3.2% | 4.4% | -7.9% | 43.1% | -51.1% | -18.2% | -18.4% | |
| 25.0% | 6.6% | -8.4% | -16.6% | -8.6% | 5.0% | 28.8% | -2.5% | 5.9% | -50.6% | -0.6% | 13.9% | |
| 20.2% | -0.1% | -4.7% | 27.3% | -3.9% | 9.1% | 25.0% | 5.4% | -13.4% | -24.6% | 3.4% | 21.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.